AhR signaling in skin-resident CD207 <sup>+</sup> cells is involved in UV-B-induced amelioration of neuroinflammation

N Nadine Mykicki (Department of Immunology, University of Oldenburg) J Johannes A. Eble (Institute for Physiological Chemistry and Biochemistry, University of Münster) H Heike Weighardt (LIMES–Life and Medical Science Institute) E Elena Gonnelli (Department of Dermatology, Experimental Dermatology and Immunobiology of the Skin, University of Münster) M Maria Schneeweiß (Department of Dermatology, Experimental Dermatology and Immunobiology of the Skin, University of Münster) C Charlotte Esser (Leibniz Insitut Für Umweltmedizinische Forschung–Leibniz Research Institute for Environmental Medicine) C Carsten Weishaupt (Department of Dermatology, University of Münster) M Maryam Rezaei (Institute for Physiological Chemistry and Biochemistry, University of Münster) I Irmgard Förster (LIMES–Life and Medical Science Institute) N Nicholas Schwab (Department of Neurology, Institute for Translational Neurology, University of Münster) H Heinz Wiendl (Institute for Neurology and Neurophysiology, Faculty of Medicine, University of Freiburg) B Björn E. Clausen (Institute for Molecular Medicine and Research Center for Immunotherapy (Forschungszentrum Informatik), University Medical Center of the Johannes Gutenberg-University Mainz) S Sven G. Meuth (Department of Neurology, Heinrich-Heine University Düsseldorf) K Karin Loser (Department of Immunology, University of Oldenburg)

Abstract

Environmental stimuli, including the exposure to ultraviolet (UV)-B light, are known to play a role in the modulation of immune-mediated mechanisms in multiple sclerosis (MS). In experimental autoimmune encephalomyelitis (EAE), we have shown that UV-B irradiation ameliorates disease outcome by regulatory T cells (Treg) expansion. Moreover, the UV-B-mediated induction of Treg numbers was also observed in MS. The aryl hydrocarbon receptor (AhR) can be activated by environmental factors including UV-B-induced photoproducts of tryptophan. Thus, we investigated the role of AhR during the transmission of UV-B irradiation. Therefore, wild-type (WT) and AhR-deficient mice (AhR –/– ) were irradiated with UV-B light and immunized with myelin oligodendrocyte glycoprotein (MOG)-peptide. In WT mice it was shown that UV-B irradiation reduces EAE symptoms by Treg expansion. This effect was abrogated in animals with AhR deficiency. To better understand the underlying mechanisms of AhR regulation, we used mice with a deletion of AhR specifically in different subsets of antigen-presenting cells (APC) that have been shown to mediate the expansion of Treg. Interestingly, we could show that the AhR activation in murine cutaneous APC was sufficient to switch APC from a stimulatory into a regulatory phenotype, and moreover, responsible for APC cell maturation and migration into regional lymph nodes. Thus, our data indicate that AhR activation in APC might be required for UV-B-mediated immunosuppression during MOG-induced EAE. Hence, activation of AHR in tissue-resident APC, potentially by low-dose UV-B irradiation, might be beneficial as an adjuvant treatment in inflammatory or degenerative diseases of the central nervous system.

Article Details

Volume / Issue Vol. 122, Issue 36
Published September 09, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (14)

N

Nadine Mykicki

Department of Immunology, University of Oldenburg

J

Johannes A. Eble

Institute for Physiological Chemistry and Biochemistry, University of Münster

H

Heike Weighardt

LIMES–Life and Medical Science Institute

E

Elena Gonnelli

Department of Dermatology, Experimental Dermatology and Immunobiology of the Skin, University of Münster

M

Maria Schneeweiß

Department of Dermatology, Experimental Dermatology and Immunobiology of the Skin, University of Münster

C

Charlotte Esser

Leibniz Insitut Für Umweltmedizinische Forschung–Leibniz Research Institute for Environmental Medicine

C

Carsten Weishaupt

Department of Dermatology, University of Münster

M

Maryam Rezaei

Institute for Physiological Chemistry and Biochemistry, University of Münster

I

Irmgard Förster

LIMES–Life and Medical Science Institute

N

Nicholas Schwab

Department of Neurology, Institute for Translational Neurology, University of Münster

H

Heinz Wiendl

Institute for Neurology and Neurophysiology, Faculty of Medicine, University of Freiburg

B

Björn E. Clausen

Institute for Molecular Medicine and Research Center for Immunotherapy (Forschungszentrum Informatik), University Medical Center of the Johannes Gutenberg-University Mainz

S

Sven G. Meuth

Department of Neurology, Heinrich-Heine University Düsseldorf

K

Karin Loser

Department of Immunology, University of Oldenburg